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Abstract: Structural variation in the human genome is likely to be an important 
mechanism for neuronal diversity and brain disease. A combination of multiple different 
forms of aneuploid cells due to loss or gain of whole chromosomes giving rise to cellular 
diversity at the genomic level have been described in neurons of the normal and diseased 
adult human brain. Here, we describe recent advances in molecular neuropathology based 
on the combination of slide-based cytometry with molecular biological techniques that 
will contribute to the understanding of genetic neuronal heterogeneity in the CNS and its 
potential impact on Alzheimer´s disease and age-related disorders. 
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1. Aneuploidy in the Normal and Diseased Brain 
 
Understanding the mechanisms underlying generation of neuronal variability and complexity 
remains a basic challange to neuroscience. Structural variation in the human genome is likely to be one 
important mechanism for neuronal diversity and brain disease. A combination of multiple different 
forms of aneuploid cells due to loss or gain of whole chromosomes (mosaic aneuploidy) giving rise to 
cellular diversity at the genomic level have been described in neurons of the normal and diseased adult 
human brain [1-11]. However, the incidence and regional distribution of neuronal aneuploidy in the 
human brain, whether it affects all chromosomes to the same extent and its impact on brain 
development and function still remain obscure. 
Aneuploidy is defined as the loss and/or gain of chromosomes giving raise to a numerical deviation 
from haploid genome multiples [12]. While aneuploid cells have been typically associated with 
pathophysiological conditions such as cancer [13], Down´s syndrome [14], Turner´s syndrome [15] 
and mosaic variegated aneuploidy [16] and idiopathic autism [17], cells in normal individuals have 
basically been assumed to contain identical euploid genomes [18]. Still, earlier hypotheses suggested 
that a number of mammalian somatic tissues are populated by polyploid cells. Adult neurons of 
mammals were assumed to be postmitotic cells characterized to some extent by a polyploid 
chromosome complement. Testing this hypothesis in the past through histochemical methods, 
however, yielded controversial results through technical limitations [19,20]. However, with the recent 
development of molecular cytogenic techniques, aneuploid cells in the normal developing and mature 
brain have clearly been identified, indicating that the maintenance of aneuploid neurons in the adult 
CNS is a widespread, if not universal, property of organisation [1-11]. 
Recent studies of the embryonic brain have shown that about approximately one-third of the 
dividing cells that give rise to the cerebral cortex have genetic variability, manifested as chromosome 
aneuploidy [3,7,21]. Neurons that comprise the adult cerebral cortex arise from mitotic neural 
progenitor cells in the ventricular zone, a proliferating region where aneuploid cells appear to be 
generated through various chromosome segregation defects initially [7,22]. While a portion of these 
aneuploid cells apparently die during development [7,23,24], aneuploid neurons have been identified 
in the mature brain in all areas assayed [3-8,11,25] indicating that aneuploidy does not necessarily 
impair viability [26]. Aneuploid neurons in the adult have been shown to make distant connections and 
express markers associated with neural activity which indicates that these neurons can be integrated 
into brain circuitry [18]. 
 
1.1. The overall rate of aneuploidy for the full complement of chromosomes of any vertebrate brain 
remains to be determined 
 
The overall prevalence of aneuploidy in the normal adult mammalien brain is currently unclear 
[18], and might differ with respect to brain region, type of chromosome complement and species. The 
percentage of aneuploid neurons in the human cerebellum, for example, is lower than that in the 
cerebral cortex or olfactory bulb [9], suggesting that there might be inherent differences in the rates of 
mosaic aneuploidy between brain regions. Int. J. Mol. Sci. 2009, 10               
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Analyses of sex chromosomes in postmitotic cells from mouse cortex and olfactory bulb using 
chromosome-specific paints indicate that about 1-6% of cells have gained or lost sex chromosomes  
[3,7,23]. Similar analyses in humans using whole-chromosome paint and locus-specific point probes 
indicate that about 4% of brain cells, including postmitotic neurons as well as non-neuronal cells, have 
lost or gained chromosome 21 [7]. A more recent study has even reported an aneuploid rate of 13% for 
chromosome 21 in hippocampal neurons of the normal adult human brain [27]. In our own studies on 
chromosome 17 in the entorhinal cortex of the normal adult human brain, we observed an aneuploid 
rate between 6% and 19% [5]. If these rates of aneuploidy for chromosomes 21 and 17 are indicative 
of the rates for other chromosomes, the total percentage of aneuploid neurons would represent a 
considerable quantity in the adult brain. In support of this assumption, Osada et al. [25] observed that 
64% of normal murine cerebral cortical nuclei have deviations from the euploid karotype following 
nuclear transfer to oocytes. 
A major drawback of these initial studies on aneuploidy in the adult human brain is the fact that for 
technical reasons, analyses are performed on isolated cellular nuclei. This prevents clear attribution of 
cytogenetic changes to define subsets of cells and to study these changes in a cytoarchitectonic context 
of preserved tissue architecture. These technical restrictions make it difficult to study the potential link 
between cytogenetic cellular individuality and selective neuronal vulnerability which itself follows a 
defined distribution throughout different brain areas (see below), and, thus, require the implementation 
of novel techniques. Further, it obscures a clear cut differentiation between neurons as postmitotic cells 
and glial cells as potentially proliferating cells. Thus, the rate of aneuploidy for the full complement of 
chromosomes from mouse, human or any other vertebrate brain remains to be determined. 
 
1.2. It is unclear what degree of aneuploidy a single cell can support and still survive in the adult brain 
 
When neural progenitor cells are placed into culture with fibroblast growth factor 2 to promote stem 
cell expansion, a reduction in aneuploidy is observed in the mitotic population. This change can be 
attributed to a preferential loss of aneuploid cells, indicating their higher susceptibility [7]. 
Alternatively, however, it could be assumed that aneuploid cells are less well able to proliferate and 
instead exit the cell cycle and terminally differentiate. A marked decrease in the rate of aneuploidy was 
also observed during brain development, potentially indicating a higher rate of elimination due to 
higher susceptibility to cell death. While the rate of aneuploidy in proliferating neuroblasts is as high 
as 33% [7,21], it decreases to about 10% in the postmitotic cells in the adult brain [5,11,28]. The 
apoptotic clearance of neuronal cells observed during cortical development [26] might be influenced 
by inherited mutations in genes implicated in the maintenance of chromosome stability. 
Alterations in mechanisms of apoptotic clearance may result in a lack of abnormal neuronal 
clearance, leading, therefore, to neurodevelopmental abnormalities in childhood. As the onset of 
neuronal apoptosis is age dependent, the persistence of aneuploidy/polyploidy in the brain throughout 
postnatal life may be the cause of extensive apoptosis. Because extensive apoptotic clearance should 
disturb the maintenance of the established neuronal cell content in the adult brain, it may be considered 
a cause of late-onset neurodegenerative diseases. Different types of chromosomal imbalances may 
relate to an uneven apoptotic signaling potential. Polyploidy seems to be more significantly involved 
in the neuronal cell death of postmortem brain samples from AD [10], in contrast to the persistence of Int. J. Mol. Sci. 2009, 10               
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aneuploidy in the normal and schizophrenic brain [11,29,30]. Therefore, each type of chromosome 
complement abnormality might possess a different propensity for apoptotic clearance. 
 
1.3. Caution for stem cell therapy 
 
Transplantation of neural stem cells have been suggested as a potential therapeutic tool to treat CNS 
disorders. As a source of neural stem cells is the developing brain [31], its characteristic features 
should be reevaluated. The high rate of aneuploidy of mammalian neuronal stem cells, which amounts 
to about 30% [7,11], however, has not been considered in this context. If, further, organotypic 
cultivation commonly used to expand the stem cell population induces aneuploidy [11,21], it might 
cause a considerable risk to use such aneuploid cells that show a high rate of neoplastic transformation 
[13,32] for therapeutic purposes. The rate of chromosomal abnormalities in human oocytes rages from 
10 to 20% [33,34]. The rate of chromosomal mosaicism in preimplantation embryos analyzed at 
different stages varies widely from 15 to 90%. 
 
1.4. The functional significance of a brain composed of an intermixed population of aneuploid and 
euploid neurons is currently unknown 
 
One possibility is that aneuploidy serves a mechanism for generating cellular diversity within the 
CNS. Indeed, aneuploid cells display distinct gene expression profiles compared with euploid cells 
from the same lineage as shown in a mouse model of loss of heterozygosity [3]. This indicates that 
functional gene expression can be permanently altered in living cells by chromosomal aneuploidy. 
As shown recently, moreover, human autosomes typically show a high rate of random monoallelic 
gene silencing, expressing only either the maternal or the paternal allel [35]. This can clearly lead to 
differences in expressed protein sequences and to differences in levels of gene expression, a 
mechanism that further enhances molecular diversity of individual cells. It remains comletely 
unknown whether similar mechanisms of silencing single allels might be active if due to aneuploidy 
multiple copies of a single allel are present in a cell. 
Through alterations in gene dosage by chromosomal gain or loss, aneuploid cells may also increase 
susceptibility to disease, as has been suggested for germline mutations resulting in large-scale copy 
number polymorphisms [36] and locus triplications [37]. 
Moreover, aneuploidy due to meiotic errors is the most common cause of fetal death, stillbirth, and 
disorders associated with chromosome abnormalities in humans [38,39]. Apart from trisomy of 
chromosomes 13, 18, and 21, as well as additional supernumerary marker chromosomes, all remaining 
autosomal aneuploidy conditions are supposed to occur in liveborns as mosaic forms only. Mental 
impairment is a characteristic feature of all recognizable autosomal aneuploidy syndromes. It is 
frequently accompanied by morphological changes in the brain of affected children, supporting the 
contention that the presence of neuronal cells with a gained or lost autosome may be related not only to 
impaired functioning but to conspicuous morphological abnormalities [40]. 
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1.5. Chromosomal mosaicism confined to the brain might involve different chromosomes relevant to 
aging and common brain disorders 
 
The two best studied biological processes associated with numerical chromosome imbalances are 
tumorigenesis and aging. Brain tumors demonstrate aneuploid karyotypes in at least about 50% of 
cases [41,42]. The variation of chromosome complement observed at the cytogenetic level as a feature 
of human aging has been well documented [43-45]. More recently, this penomenon was found to be 
likely explained by mitotic misregulation [46]. Although tissue-specific chromosome complement 
variation in human aging is poorly understood, current data provide indirect evidence for an acquired 
aneuploidy in numerous tissues. In addition, the CNS possesses parts in which long-term production of 
neurons occur and, therefore, low-level chromosomal mosaicism in the human brain may also 
contribute to aging processes either through mitotic errors or the onset of expression of age-related 
genes in aneuploid mature neurons. 
Human diseases with reported aneuploidy include Alzheimer´s disease [7,12,27,47-54], Down´s 
syndrome [55-58], ataxia-telangiectasia [28], schizophrenia [29, 59-64], mosaic variegated aneuploidy 
[16, 65-68], and various tumors such as gliomas, glioblastomas and medulloblastomas [41,69,70-72]. 
Early studies on AD have proposed a link between aneuploidy, particular of chromosome 21, and 
AD. This suggestion was based on two observations. First, the gene coding for APP which through 
abnormal processing gives rise to Aß being critically involved in AD pathology, is located on 
chromosome 21. Second, Down´s patients, trisomic for chromosme 21, frequently develop an AD-type 
pathology at higher age. Subsequent studies on gene dosage of chromosome 21 gene in AD, however, 
have reported conflicting results and the actual role of gene dosage through trisomy 21 in AD remains 
controversial. Prior studies using allele-specific PCR on sporadic and familial AD cases have failed to 
observe dosage increase [73-75]. Notably, these PCR approaches might have lacked the sensitivity to 
detect increased mosaic levels of trisomy compared to controls. In addition, increased trisomy could be 
masked by the possibility that neural trisomy shows spatial variation, combined with the known 
existence of chromosome 21 monosomy. Furthermore, a recent study of five families with autosomal 
dominant early-onset AD and hereditary dementia with cerebral amyloid angiopathy showed 
duplication of the APP locus on chromosome 21, as verified by quantitative multiplex PCR and dual 
FISH [76]. 
Whether there are significant levels of trisomy 21 in the brains of AD patients is still unknown. The 
longevity of postmitotic neurons might provide more time for the accumulation of aneuploidy, in 
contrast to more rapidly cycling populations. This suggestion is supported by the observation of 
significant levels of chromosome 21 monosomy and trisomy in normal human neural tissue compared 
to lymphocytes [8]. 
Thus, future studies will be neccessary to directly address the question whether AD is characterised 
by increased aneuploidy of one particular chromosome (e.g. 21) or perhaps by multiple chromosomes 
as in diseases like schizophrenia or cancer [29]. 
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2. Selective Vulnerability of Cortical Neurons Reflect the Modular Cortical Structure  
 
Neurodegenerative changes in AD are not randomly distributed throughout the cerebral cortex but 
rather follow a defined pattern of progression that provides the basis for the neuropathological staging 
[77]. Both, certain cortical areas and types of neurons are earlier and more constanly involved than 
others. Neurofibrillary degeneration in the cerebral cortex preferentially affects lamina III and V 
pyramidal neurons, leaving interneurons unaffected. Further, degeneration preferentially affects the 
limbic cortex and cortical association areas while primary sensory and motor areas are largely spared. 
The reasons for this selective neuronal vulnerability are unkown. 
Neurofibrillary degeneration in the cerebral cortex, moreover, typically occurs in clusters. Degene-
ration predominantly involves pyramidal neurons within supra- and infragranular layers with the 
clustering in these layers often being in register with each other [78] indicating a columnar 
organisation of degeneration [79]. This NFT clustering is highly correlated with symptoms [80]. Also 
plaques appear to show a degree of vertical clustering between apical dendritic clusters [81]. 
The columnar structure is disorganised in cortical areas affected by pathology in AD [82]. Cortical 
atrophy in AD, moreover, is due to a decrease in cortical length indicating a shrinkage or loss of 
columns while cortical thickness remains unaffected [83,84]. Also during normal aging, minicolumn 
width shinks in those cortical regions that are potentially vulnerable to degeneration in AD [85]. A 
study on trisomy 21 Down´s patients, furthermore, suggest that children with the disorder exhibit early 
adult-like neuronal mini-column spacing [86]. This may relate to the apparently accelerated aging and 
early onset of AD in Down´s syndrome. 
This issue of columnar organisation and clustering has been pursued with respect to other patholo-
gical structures. Disruption of the columnar organisation of glial processes has been reported for AD 
[87]. Lewy bodies and Pick bodies [88,89] also exhibit clustered distribution which reflect a modular 
structure. Taken together, available evidence on the distribution of cortical pathology indicates a 
determination of the pattern of pathology through the modular organisation of the cortex [90] which 
basically is a structural reflection of its ontogeny. 
 
3. Ontogenetic and Phylogenetic Aspects of Brain Pathology 
 
AD is a disorder that selectively affects the human brain. It has been suggested that AD is specific 
to man because of molecular genetic events which promoted a rapid evolution of the hominid brain 
[91,92]. The phylogenetic expansion of the hominid neocortex most likely arose through a rapid 
multiplication of the fundamental columnar building blocks. 
During embryonic development of the cerebral cortex, cells migrate towards the surface and form 
mini-columns of cells. They appear to be grouped into larger macro-columns, which form the basis of 
the mapping of functions across the brain´s surface. 
Pyramidal neurons, potentially vulnerable to neurofibrillary degeneration in AD, according to the 
radial unit hypothesis, derive from radially migrating neurons that originate in the ventricular zone of 
the pallium (cortex). In the primate brain, they find their way to the distant cortex by using radially 
oriented glial fibres as guides. On the contrary, cortical interneurons, unaffected by degeneration in Int. J. Mol. Sci. 2009, 10               
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AD, are born outside the cortex in the ganglionic eminence and reach their final position through 
tangential migration [93,94]. 
Following the last mitotic division, immature neurons of the ventricular and sub-ventricular zones 
attach to an adjacent set of glial guidance fibres. Thus, clonally related neurons generated serially in 
time at the same locus in the germinal epithelium migrate sequentially along the same or adjacent set 
of glial guidance fibres, and settle in the inside to outside pattern aligned in a single vertical column 
[95-97]. Neurons of this radial column form an ontogenetic unit, the fundamental building block in the 
developing neocortex [98]. Thus, the basic columnar organisation of the cortex reflects its mode of 
generation [99-101]. 
The evolutionary expansion of neocortical size in mammals which is particularly prominent in 
anthropoid primates (i.e. monkeys, apaes, humans) reflects an increased number of cortical cells. 
According to the radial unit hypothesis, this phylogenetic expansion in cortical surface area results 
from an increase in the number of founder cells prior to neurogenesis. This increase in the number of 
cells is generated by two mechanisms: (i) an increase in the size of the embryonic subventricular zone 
and (ii) a prolonged period of cell cycle activity of progenitor cells during neurogenesis [102]. In 
macaque monkey, the period during which cell division occurs is 10 times longer than in rodent and 
the cell cycle duration is two to five times longer than in mouse [103]. Substantially more total rounds 
of cell divisions elapse during the prolonged neurogenetic period of the monkey cortex, providing the 
basis for increased cell proliferation. Moreover, unlike the progressive slowing that occurs during 
cortical development in rodents, cell division accelerates during neurogenesis of the enlarged cortical 
layers in monkeys. These findings suggest that evolutionary modifications of the duration and number 
of progenitor cell divisions contribute to both the expansion and laminar elaboration of the primate 
neocortex [104]. The enlarged cortex of great apes reflects a longer period of neuronal formation 
during pre-natal development, so that each dividing progenitor cell undergoes more cell cycles before 
stopping cell division [104]. Cortical progenitors undergo 11 rounds of cell division in mice [105], at 
least 28 in the macaque [104], and probable four more in human [106]. This phylogenetic prolongation 
of mitotic activity provides the basis for a potentially higher rate of accumulating mitotic errors during 
neurogenesis. It is unclear, however, whether different mammalian species differ with respect to the 
frequency of aneuploid neurons in the CNS. 
 
4. A Cytomic Approach to Study Molecular Brain Architecture 
 
Until recently, the DNA amounts of defined single neurons have been difficult to study under 
conditions of preserved tissue architecture. Although chromosome mapping on interphase nuclei by 
fluorescence in situ hybridisation (FISH) has made considerable progress in recent years [4,7,21,107], 
it still suffers from major technical limitations. These limitations mainly arise from the application of 
FISH to isolated cellular nuclei which prevents from clearly attributing cytogenetic changes to defined 
subsets of cells and to study these changes in a cytoarchitectonic context of preserved tissue 
architecture. These technical restrictions make it difficult to study the potential link between 
cytogenetic individuality and selective neuronal vulnerability and, thus, require the implementation of 
novel techniques. Int. J. Mol. Sci. 2009, 10               
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Therefore, we have developed a novel approach for the DNA quantification of single identified 
neurons in brain slices based on a combination of slide-based cytometry (SBC) after DNA staining 
with propidiumiodide, chromogenic in situ hybridisation (CISH) with chromosome-specific probes 
and laser microdissection followed by quantitative PCR (qPCR) of alu repeats [5,108]. All three 
methods are applicable to tissue sections and can be combined with immunocytochemical detection of 
specific marker proteins which allow for further specification of cellular identity in the context of 
preserved tissue architecture. This is a clear advantage when analysing tissue sections containing 
different cell types (e.g. neurons versus glia) and modes of pathological affections (e.g. cytoplasmic 
inclusions, neurofibrillary degeneration). 
To confirm our experimental approach we cross validated the three methods, i.e SBC, CISH and 
qPCR through subsequent application one by one to a defined subset of microscopically identified 
neurons and obtained a remarkably high inter-method reliability (Figure 1). Obviously, this 
combination of the three methods in a row can be easily adapted to other issues. When the PI intergral 
(SBC) is plotted against the number of hybridisation spots (CISH), a highly significant correlation will 
be obtained (Figure 1A). Similarly, the PI integral shows a highly significant correlation with the DNA 
content determined by PCR amplification of alu repeats (Figure 1B). The DNA amount determined by 
PCR amplification of alu repeats also correlates highly significantly with the number of hybridisation 
spots (Figure 1C). 
 
Figure 1. Inter-method reliability of three independent methods for single cell DNA 
quantification. A set of 48 microscopically identified neurons of the entorhinal cortex in a 
patient with early AD was evaluated through subsequent application of SBC, CISH and 
PCR amplification of alu repeats. Tissue sections were first processed for SBC, followed 
by hybridization with a chromosome 17-specific probe. Subsequently, indentified neurons 
were captured through laser microdissection and subjected to PCR amplification of alu 
repeats. Regression analyses reveal correlation coefficients according to Bravais-Pearson 
of (A) r = 0.92 for the SBC data versus hybridization results (CISH), (B) of r = 0.80 for 
LSC versus PCR amplification and (C) r =  0.78 for PCR amplification versus 
hybridization. All correlation coefficients are significant at p < 0.001 (adapted from [5]). 
 
 
 
 
 
 
 
 
 
 
Based on these correlations, the DNA amount (mean ± SD) of a single diploid neuron identified by 
two hybridisation spots can be determined as 2.52 ± 0.87 pg, while the DNA content of a neuron with 
four spots amounts to 5.94 ± 1.28 pg. For comparison, the mean single cell DNA content (±SD) of 
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lymphocytes treated identically to brain tissue and used for control experiments was determined at 
2.07 pg ± 0.6 pg. 
As in our studies the DNA content of single neurons determined by SBC is far better correlated to 
CISH (Figure 1A) than is the qPCR measurement (Figures 1B/C), we conclude that SBC is a very 
reliable technique for future studies on the single cell DNA content in tissue sections. 
 
4.1. Quantification of single neuron DNA amount by Slide-based Cytometry (SBC) 
 
For cytometric quantification of DNA, neurons of the entorhinal cortex were identified by immuno-
cytochemical detection with the pan-neuronal neurofilament marker SMI311 and counter-reacted with 
PI [5]. DNA analysis by SBC identified the majority of neurons in controls as diploid. In our study, we 
identified about 88% of neurons in control brains with a DNA amount of 2n, while about 12% had a 
hyperploid DNA content between 2n (diploid) and 4n (tetraploid). About 0.4% of neurons contained a 
tetrasomic DNA content (Figure 2). In AD, a significant shift of neurons from the diploid to 
hyperploid and tetraploid DNA content was observed. Neurons with a diploid DNA content were 
reduced to 77% and 70 % in early and advanced AD, respectively, while the fraction of neurons 
containing DNA between 2n and 4n was increased to 21% and 29%. The frequency of neurons with a 
tetrasomic content of DNA was increased in early AD by factor six (2.4%) and more than doubled in 
advanced AD (1.1%). 
 
Figure 2. Quantification of single-neuron DNA content by SBC. Note the increase in 
aneuploid neurons in AD. (control: n=13; AD early stages, Braak stage I/II: n=6; AD late 
stages, Braak stage V/VI: n=7; * p<0.01; adapted from [5]. 
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4.2. Chromogenic in situ hybridization 
 
After chromogenic in situ hybridisation (CISH) with a chromosome 17 probe on brain sections, 
two hybridisation spots were obtained for the majority of neurons in the entorhinal cortex of both 
controls and AD [5]. In addition, neurons with none, one or three spots were observed. A small but 
constant number of neurons in both controls and AD displayed four hybridisation spots. The number 
of nuclei with three hybridisation spots was doubled in AD compared to controls (controls: 6%; AD 
early: 12%; AD advanced: 13%). In controls, a small portion of about 0.3 % of neurons showed four 
hybridisation spots. The relative number of these neurons with four spots was increased in AD by 
factor four to five (early AD: 1.3%; advanced AD: 1.5%) (Figure 3). 
 
Figure 3. Quantification of CISH signals (chromosome 17 probe) in neurons of the 
entorhinal cortex (For number of cases compare Figure 2; *p<0.01; adapted from [5]). 
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Subsequently to CISH, we further analysed the single cell DNA content on the same sections by 
laser capture microdissection of neurons individually identified under the microscope and subsequent 
PCR amplification of alu repeats [5]. The frequency distribution of single cell DNA content obtained 
by this method is displayed in Figure 4. Comparing AD to controls, a shift towards higher size classes 
and differences in the shape of the distribution becomes apparent. The distributions of control groups 
have a single maximum at 2.5-3.5 pg per cell which corresponds to the size for a 2n DNA content as 
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Figure 4. Frequency distribution of single neuron DNA-content determined by PCR 
amplification of alu repeats. Note in AD the shift towards higher DNA content and   
the appearance of a second peak corresponding to a tetraploid DNA content   
(adapted from [5]). 
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5. Conclusions 
 
The results of the present study on the DNA amount of identified cortical neurons, obtained through 
a combination of slide-based cytometry, chromogenic in situ hybridization and PCR amplification of 
alu-repeats, indicate that at least two different mechanisms need to be distinguished giving rise to a 
tetraploid DNA content in the adult brain. Constitutional aneuploidy in differentiated neurons of the 
normal human brain might be more frequent than previously thought. It is, however, not elevated in 
AD. In addition, in AD some neurons have re-entered the cell cycle and entirely passed through a 
functional interphase with a complete DNA replication. The combination of cytometry with molecular 
biological characterisation of single microscopically identified neurons as outlined here might be a 
promising approach to study molecular neuronal individuality in the context of preserved tissue 
architecture. It reflects the concept of cytomics and will forward our understanding of the molecular 
architecture and functionality of neuronal systems
 [109,110]. 
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